Aarti Drugs Limited
Aarti Drugs Limited (AARTIDRUGS.NS) Stock Overview
Explore Aarti Drugs Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
33.7B
P/E Ratio
16.66
EPS (TTM)
$22.09
ROE
0.15%
AARTIDRUGS.NS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Aarti Drugs Limited (AARTIDRUGS.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 40.84, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $347.02.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 16.66 and a market capitalization of 33.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.